Biocompatible alloy and medical product

US2019201576A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2019201576-A1
Application numberUS-201716328677-A
CountryUS
Kind codeA1
Filing dateAug 21, 2017
Priority dateSep 8, 2016
Publication dateJul 4, 2019
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a biocompatible alloy having low magnetic susceptibility and excellent mechanical properties. The biocompatible alloy according to the present invention contains: Zr as a main component; Nb of not less than 0.1% by mass and not greater than 25% by mass; Mo of not less than 0.1% by mass and not greater than 25% by mass; and Ta of not less than 0.1% by mass and not greater than 25% by mass. A total content of Nb, Mo, and Ta in the biocompatible alloy is not less than 2% by mass and not greater than 50% by mass. The biocompatible alloy has a mass susceptibility of not greater than 1.50×10−6 cm3/g. The biocompatible alloy has a Young's Modulus of not greater than 100 GPa. Various biocompatible implants and medical devices can be manufactured from the biocompatible alloy.

First claim

Opening claim text (preview).

1 . A biocompatible alloy comprising: Zr as a main component; Nb of not less than 0.1% by mass and not greater than 25% by mass; Mo of not less than 0.1% by mass and not greater than 25% by mass; and Ta of not less than 0.1% by mass and not greater than 25% by mass. 2 . The biocompatible alloy according to claim 1 , wherein a total content of Nb, Mo, and Ta is not less than 2% by mass and not greater than 50% by mass. 3 . The biocompatible alloy according to claim 1 , wherein the Nb content is not less than 0.5% by mass and not greater than 25% by mass, the Mo content is not less than 0.1% by mass and not greater than by mass, and the Ta content is not less than 1.0% by mass and not greater than 15% by mass. 4 . The biocompatible alloy according to claim 1 , wherein the Nb content is not less than 12% by mass and not greater than 16% by mass, the Mo content is not less than 0.5% by mass and not greater than 5% by mass, and the Ta content is not less than 3% by mass and not greater than 12% by mass. 5 . The biocompatible alloy according to claim 1 , wherein a ratio (PMo/PTa) of PMo, which is the Mo content (% by mass), to PTa, which is the Ta content (% by mass), is not less than 1/20 and not greater than 1/3. 6 . The biocompatible alloy according to claim 1 , wherein the biocompatible alloy has a mass susceptibility of not greater than 1.50×10 −6 cm 3 /g. 7 . The biocompatible alloy according to claim 1 , wherein the biocompatible alloy has a Young's Modulus of not greater than 100 GPa. 8 . A medical product made of the biocompatible alloy according to claim 1 .

Assignees

Inventors

Classifications

  • comprising metals or alloys · CPC title

  • Inorganic materials · CPC title

  • A61L27/04Primary

    Metals or alloys · CPC title

  • Metals or alloys · CPC title

  • A61L27/047Primary

    Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2019201576A1 cover?
Provided is a biocompatible alloy having low magnetic susceptibility and excellent mechanical properties. The biocompatible alloy according to the present invention contains: Zr as a main component; Nb of not less than 0.1% by mass and not greater than 25% by mass; Mo of not less than 0.1% by mass and not greater than 25% by mass; and Ta of not less than 0.1% by mass and not greater than 25% by…
Who is the assignee on this patent?
Tokusen Kogyo Kk, Univ Nat Corp Tokyo Medical & Dental
What technology area does this patent fall under?
Primary CPC classification A61L27/04. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jul 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).